Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Infosys Foundation Commits INR 100 Crore Towards COVID-19 Relief Efforts

Posted On: 2020-03-30 21:10:19


Infosys Foundation, the philanthropic and CSR arm of Infosys, today announced that it is committing INR 100 crore to support efforts towards fighting COVID-19 in India. The Foundation contributed half of this commitment (INR 50 crore) to the PM CARES Fund.

This sum will primarily be utilized across three broad areas of support that the Foundation has prioritized:

- To expand hospital capacity for treatment and enable hospital stays for COVID-19 patients across India, especially ones belonging to the economically weaker sections of the society

- To provide ventilators, testing kits, and Personal Protective Equipment (PPE) like masks, and other protective gear for frontline healthcare workers

- To ensure better access to food and nutrition for the underprivileged section of the society, that is bearing the adverse economic impact of the current situation.

Over the last two weeks, Infosys Foundation has announced support for creation of an exclusive hospital in Bangalore for COVID-19 patients. It has also enabled the acquisition of medical and PPE equipment for multiple military and government hospitals across the country. The Foundation is also supporting various NGOs that provide food and hygiene kits to thousands of people in need.

"These are unprecedented times that require every section of the society to rise up to the challenge. Infosys Foundation has always supported the needs of the country in difficult situations and we will continue to work with governments, non-profits, and healthcare institutions in their fight against this global pandemic. All our efforts will be targeted towards ensuring that the relief material reaches the people who need it the most, whether it is a patient who cannot afford treatment, our healthcare personnel, or daily-wage workers whose livelihood has been severely impacted," said Mrs. Sudha Murty, Chairperson, Infosys Foundation.

Salil Parekh, CEO and MD, Infosys, said, "The COVID-19 pandemic is one of the toughest challenges that the world has been faced with. At such a time, it is imperative for businesses to join hands with the governments, civil society, as well as healthcare institutions to support the communities we live and serve in. Infosys Foundations, both in India and in the USA, are extending their resources and technological capabilities to help people who are most impacted by this pandemic."

Infosys Foundation is already working with multiple state governments and NGOs to expand its reach across the country. If any state government, healthcare provider, or an NGO would like additional support in their relief efforts, please do reach out to us at foundation@infosys.com with your specific requests. We are happy to evaluate and consider supporting initiatives that align with our areas of focus.

Shares of INFOSYS LTD. was last trading in BSE at Rs.627.2 as compared to the previous close of Rs. 653.55. The total number of shares traded during the day was 1128539 in over 16356 trades.

The stock hit an intraday high of Rs. 664 and intraday low of 621.95. The net turnover during the day was Rs. 717883278.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

RPG Life Sciences Ltd Q4 net profit at Rs. 2.98 crore

Kirloskar Brothers Ltd Q4 consolidated net profit at Rs. 23 crore

Silver Lake and Co-Investors to invest additional Rs. 4,546.80 crore in Jio Platforms

Saurashtra Cement Ltd takes annual maintenance shutdown at Ranavav factory

TIMKEN India Ltd board recommends dividend of Rs. 50

RPG Life Sciences Q4'FY 20 revenue up by 29%

Infibeam Avenues announces Fourth Quarter and Fiscal Year 2020 Results

L&T reports consolidated earnings for Q4, FY2020

Refex Industries Limited board to finalize rights issue terms

Greaves accelerates performance in new business initiatives with 21% contribution in FY20

TIMKEN India Ltd Q4 PAT at Rs. 61.26 crore

Natural Capsules Ltd posts Rs. 0.11 crore in Q4 FY20

SMS Pharmaceuticals Ltd Q4 PAT drops to Rs. 6.32 crore

Sumitomo Chemical India Ltd Q4 consolidated PAT at Rs. 22.90 crore

L&T Board recommends Final Dividend of Rs. 8

Natural Capsules Ltd Board approves dividend of Rs. 0.60

Jyothy Labs Ltd Q4 FY20 consolidated PAT at Rs. 28.80 crore

Aditya Birla Capital Ltd reports consolidated Q4 PAT of Rs. 143.67 crore

PPAP Automotive Ltd reports consolidated PAT of Rs. 5.85 crore in Q4 FY20

CG-VAK Software & Exports Ltd Q4 consolidated PAT at Rs. 1.28 crore

Exide Industries Ltd reports lower top line in Q4 FY2020

Gateway Distriparks Ltd announces FY2020 performance

CG-VAK Software and Exports Ltd board recommends dividend of Rs. 0.75 for FY20

Infibeam Avenues Ltd to acquire Cardpay Technologies Pvt Ltd

Pfizer Ltd Board to consider FY20 results & Final Dividend on June 15, 2020

Sumitomo Chemical India Ltd board declares dividend of Rs. 0.55

IRB InvIT Fund board declares 4th distribution of Rs. 1.80 for FY2020

Apollo Pipes Ltd launches water storage tank

Gujarat Gas Ltd Q4 consolidated PAT at Rs. 250.46 crore

Dr. Kiran Mazumdar-Shaw from India named EY World Entrepreneur Of The Year™ 2020

Alkem Laboratories Ltd Board approves final dividend of Rs. 3

SBI - Q4 / FY2020 Highlights

Mahindra to plant a tree for every service availed digitally on its With You Hamesha app

V-Guard presents new range of AIKIDO air coolers to beat the heat

IndiGo operates flight chartered by NALSAR to transport 174 migrant workers

Maruti Suzuki sells over 1 lakh factory fitted CNG vehicles - Highest ever in a fiscal

Alkem Laboratories Ltd Q4FY20 consolidated PAT at Rs. 188.77 crore

Lasa Supergenerics Ltd Q4 FY2020 PAT at Rs. 2.58 crore

Saregama India Ltd Board recommends dividend of Rs. 1.50

SBI Q4 FY20 consolidated PAT at Rs. 6909.95 crore

Suven Life Sciences Ltd reports loss of Rs. 25.55 crore in Q4 FY20

Saregama India Ltd Q4 consolidated PAT at Rs. 15.81 crore

Snowman reports optimistic results in pessimistic market outlook backed by Strong Fundamentals and Robust Business Model

Zydus Cadila receives final approval from USFDA for Atazanavir Capsules

Cheviot Company Ltd Q4 PAT falls to Rs. 3.50 crore

JSW Steel Ltd allots 10,000 NCDs

Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients

Maruti Suzuki commissions 5 MW carport style photovoltaic solar power plant in Gurugram

Hexaware Technologies Ltd board to consider voluntary delisting on June 12, 2020, stock locked in upper circuit

TCS Wins 2020 SAP® Pinnacle Award







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019